‌

US Patent 9483620 Reminder programming device and method

Patent 9483620 was granted and assigned to Novo Nordisk on November, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
1
Current Assignee
Novo Nordisk
Novo Nordisk
1
Date Filed
April 8, 2011
1
Date of Patent
November 1, 2016
1
Patent Application Number
13639267
1
Patent Citations Received
‌
US Patent 11904145 Diabetes therapy management systems, methods, and devices
2
‌
US Patent 11931549 User interface for diabetes management systems and devices
3
‌
US Patent 11918789 Therapy management systems, methods, and devices
4
‌
US Patent 11957884 Insulin injection assistance systems, methods, and devices
5
‌
US Patent 11948671 Intelligent accessories for medicine dispensing device
6
‌
US Patent 11944465 Monitor user interface for diabetes management systems including flash glucose
7
‌
US Patent 11771835 Therapy assist information and/or tracking device and related methods and systems
Patent Inventor Names
Soeren Dybdal Reimer
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
9483620
1
Patent Primary Examiner
‌
Thomas Mullen
1

Find more entities like US Patent 9483620 Reminder programming device and method

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.